Received Jun 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (ACTHIB) | SANOFI PASTEUR | UNK | — | OT |
ACTHIB was prepared with 0.7 ml SW as diluent with no reported adverse event; Initial information received on 04-Jun-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a patient with unknown age and gender who was administered with HIB (PRP/T) Vaccine [ACT-HIB] which was prepared with 0.7 ml SW as diluent with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose suspect HIB (PRP/T) Vaccine, Powder and solvent for solution for injection (lot number, expiry date and strength not reported) for Immunisation and it was prepared with 0.7 ml SW as diluent with no reported adverse event (single component of a two-component product administered). Information on the batch number was requested corresponding to the one at time of event occurrence. Reportedly, they asked for appropriate follow up and any potential side effect. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.